DVA - Kapitalisasi marang volume dodolan DaVita HealthCare Partners
DaVita Inc. (DVA) dominance in the dialysis segment and stringent regulatory standards create insurmountable barriers to entry for new players, ensuring stable demand. Fluctuations in the P/S multiple clearly demonstrate the business valuation dynamics, while the 0.80 indicator reflects the status of the current value. The company's financial foundation relies on the operation of a global network of specialized centers for patients with kidney failure.
Rincian metrik lan analitis perusahaan DaVita Inc (DVA)
- rega lan prakiraan konsensus rega:
- statistik kapitalisasi pasar:
- informasi kapitalisasi buku:
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal DaVita Inc.|DVA - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang modal DaVita Corp|DVA - Gunggung utang perusahaan|Utang marang nilai buku DaVita Inc|DVA - Kewajiban jangka dawa perusahaan|Gunggunge utang jangka cendhak DaVita|Rasio likuiditas darurat davita.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
DVA - Penghasilan resik|Bathi sing dikarepake DaVita Inc.|DVA - Pangali P/E|Pangali Forward P/E DaVita HealthCare Partners|DVA - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan DaVita Inc|DVA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku DaVita|DVA - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan davita.com|DVA - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep DaVita Inc.
- indikator pendapatan dodolan lan penghasilan bisnis:
Analisis umum perusahaan:DVA (davita.com)
To protect capital from market volatility, it is essential for an investor to determine the fair value of the business via the price-to-sales ratio. The stable influx of patients into the DaVita Inc. (DVA) dialysis center ecosystem confirms revenue resilience, allowing for the use of the price-to-sales multiple to analyze the premium paid for every dollar of revenue under strict Medicare tariff regulations.
Karo sapa DaVita Inc. saingan
Koefisien rega marang pendapatan hcahealthcare.com|Tenet Healthcare Corporation - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan FMS (Fresenius Medical Care AG)|Solventum Inc. - Multiplikator P/S|EHC - Multiplikator P/S|UHS (uhsinc.com) - Kapitalisasi marang pendapatan|radnet.com - Rasio kapitalisasi pasar marang pendapatan|OPCH (Option Care Health, Inc.) - Multiplikator P/S|Surgery Partners Inc (SGRY) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Premier Corp (PINC)|America's Best Contacts & Eyeglasses - Rasio kapitalisasi marang pendapatan|Multiplikator P/S PGNY (Progyny, Inc.)|ARDT - Kapitalisasi marang pendapatan|SEM: Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan Astrana Health Inc ASTH|MD: Multiplikator P/S|Rasio kapitalisasi marang pendapatan USPH|Kapitalisasi marang pendapatan PNTG|Rasio rega marang pendapatan ORGO|Multiplikator P/S NUTX|Multiplikator P/S Auna S.A. (AUNA)|SBC Medical Group Holdings Inc. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan EOLS (Evolus Corp)|CYH - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan SKIN (The Beauty Health)|MDWD: Multiplikator P/S|Rega marang dodolan Biote (BTMD)|JYNT (The Joint Corporation) - Multiplikator P/S|Multiplikator P/S DocGo, Inc|Kapitalisasi marang pendapatan PIII (P3 Health Partners Inc.)|Kapitalisasi marang volume dodolan GANX|Rasio rega marang pendapatan EUDA Health Holdings Limited EUDA|BMGL - Kapitalisasi marang pendapatan|CollPlant Ltd - Multiplikator P/S|Rega marang dodolan Cuprina Holdings Limited|Concord Medical Services (CCM) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan AMS|Kapitalisasi marang pendapatan MRM|ALBT (Avalon GloboCare Corporation) - Kapitalisasi marang volume dodolan|Multiplikator P/S DHAI|Carmell Corp - Rasio kapitalisasi marang pendapatan|Multiplikator P/S NIVF (NewGenIvf Group Limited)|Multiplikator P/S ATI Physical Therapy Inc. ATIP|CMAX: Kapitalisasi marang pendapatan|KDLY: Rasio rega marang pendapatan|MODV: Multiplikator P/S|NVOS - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan SSY|BACK (imacholdings.comm) - Kapitalisasi marang volume dodolan
